Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer
2024 · International Journal of Clinical Oncology · 6 citations
https://doi.org/10.1007/s10147-024-02625-w